| Literature DB >> 28926584 |
Verena Spiegler1, Andreas Hensel1, Jochen Seggewiß2, Milena Lubisch3, Eva Liebau3.
Abstract
Worldwide, more than 1 billion <span class="Species">people are affected by <span class="Disease">infestations with soil-transmitted helminths and also in veterinary medicine helminthiases are a severe threat to livestock due to emerging resistances against the common anthelmintics. Proanthocyanidins have been increasingly investigated for their anthelmintic properties, however, except for an interaction with certain proteins of the nematodes, not much is known about their mode of action. To investigate the anthelmintic activity on a molecular level, a transcriptome analysis was performed in Caenorhabditis elegans after treatment with purified and fully characterized oligomeric procyanidins (OPC). The OPCs had previously been obtained from a hydro-ethanolic (1:1) extract from the leaves of Combretum mucronatum, a plant which is traditionally used in West Africa for the treatment of helminthiasis, therefore, also the crude extract was included in the study. Significant changes in differential gene expression were observed mainly for proteins related to the intestine, many of which were located extracellularly or within cellular membranes. Among the up-regulated genes, several hitherto undescribed orthologues of structural proteins in humans were identified, but also genes that are potentially involved in the worms' defense against tannins. For example, T22D1.2, an orthologue of human basic salivary proline-rich protein (PRB) 2, and numr-1 (nuclear localized metal responsive) were found to be strongly up-regulated. Down-regulated genes were mainly associated with lysosomal activity, glycoside hydrolysis or the worms' innate immune response. No major differences were found between the groups treated with purified OPCs versus the crude extract. Investigations using GFP reporter gene constructs of T22D1.2 and numr-1 corroborated the intestine as the predominant site of the anthelmintic activity. The current findings support previous hypotheses of OPCs interacting with intestinal surface proteins and provide the first insights into the nematode's response to OPCs on a molecular level as a base for the identification of future drug targets.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28926584 PMCID: PMC5604969 DOI: 10.1371/journal.pone.0184656
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Overview of primers used for qPCR.
| Gene | Sequence name | Direction | Sequence (5’ -> 3’) |
|---|---|---|---|
| F01D4.2 | fwd | ||
| rev | |||
| F15E11.13 | fwd | ||
| rev | |||
| T22D1.2 | T22D1.2 | fwd | |
| rev | |||
| F13E9.4 | F13E9.4 | fwd | |
| rev | |||
| C54G10.3 | fwd | ||
| rev |
*pmp-3 was used as the reference gene, its primer sequences were taken from [55].
Fwd: forward, rev: reverse.
Fig 1Venn diagram showing the number of differentially regulated genes per treatment vs. the untreated negative control (DMSO 1%).
H3: OPC enriched fraction “H3”; RE: crude extract (ethanol: water 1:1). 0.02, 0.2 and 2: concentrations of 0.02 mg/mL, 0.2 mg/mL and 2 mg/mL resp., per treatment. Numbers in brackets indicate the number of differentially regulated genes per group.
Functional annotation clusters including up- and down-regulated genes obtained by DAVID.
| Category | Term | Count | PValue | Benjamini |
| UP_KEYWORDS | Hydrolase | 15 | 1.3E-4 | 3.3E-3 |
| GOTERM_MF_DIRECT | hydrolase activity | 15 | 2.3E-4 | 1.7E-2 |
| GOTERM_BP_DIRECT | lipid metabolic process | 7 | 1.3E-3 | 3.5E-2 |
| Category | Term | Count | PValue | Benjamini |
| GOTERM_CC_DIRECT | lysosome | 6 | 6.4E-6 | 1.2E-4 |
| KEGG_PATHWAY | Lysosome | 5 | 2.4E-3 | 6.7E-3 |
| UP_SEQ_FEATURE | signal peptide | 4 | 9.6E-2 | 9.1E-1 |
| Category | Term | Count | PValue | Benjamini |
| INTERPRO | Saposin B | 4 | 5.6E-4 | 3.6E-2 |
| INTERPRO | Saposin-like | 4 | 6.1E-4 | 2.7E-2 |
| SMART | SapB | 3 | 4.0E-3 | 3.7E-2 |
| UP_KEYWORDS | Disulfide bond | 7 | 9.1E-2 | 7.0E-1 |
| Category | Term | Count | PValue | Benjamini |
| GOTERM_CC_DIRECT | lysosome | 6 | 6.4E-6 | 1.2E-4 |
| SMART | Pept_C1 | 4 | 1.5E-4 | 2.8E-3 |
| INTERPRO | Peptidase C1A, papain C-terminal | 4 | 5.6E-4 | 3.6E-2 |
| INTERPRO | Peptidase C1A, papain | 4 | 5.6E-4 | 3.6E-2 |
| GOTERM_MF_DIRECT | cysteine-type endopeptidase activity | 4 | 1.8E-3 | 4.4E-2 |
| INTERPRO | Cysteine peptidase, histidine active site | 3 | 2.7E-3 | 6.9E-2 |
| GOTERM_BP_DIRECT | proteolysis involved in cellular protein catabolic process | 4 | 4.5E-3 | 8.7E-2 |
| INTERPRO | Cysteine peptidase, cysteine active site | 3 | 5.0E-3 | 1.0E-1 |
| GOTERM_MF_DIRECT | cysteine-type peptidase activity | 4 | 5.8E-3 | 1.0E-1 |
| GOTERM_CC_DIRECT | extracellular space | 5 | 1.4E-2 | 8.3E-2 |
| GOTERM_BP_DIRECT | proteolysis | 4 | 3.6E-1 | 9.5E-1 |
| UP_KEYWORDS | Protease | 3 | 3.7E-1 | 9.8E-1 |
| GOTERM_MF_DIRECT | peptidase activity | 3 | 4.0E-1 | 9.9E-1 |
| Category | Term | Count | PValue | Benjamini |
| INTERPRO | Glycoside hydrolase, catalytic domain | 3 | 5.7E-2 | 6.2E-1 |
| GOTERM_BP_DIRECT | carbohydrate metabolic process | 4 | 6.2E-2 | 4.8E-1 |
| INTERPRO | Glycoside hydrolase, superfamily | 3 | 6.9E-2 | 6.1E-1 |
| Category | Term | Count | PValue | Benjamini |
| GOTERM_CC_DIRECT | intracellular membrane-bounded organelle | 4 | 8.3E-3 | 7.6E-2 |
| GOTERM_MF_DIRECT | glucuronosyltransferase activity | 3 | 6.2E-2 | 6.1E-1 |
| GOTERM_BP_DIRECT | flavonoid biosynthetic process | 3 | 6.3E-2 | 4.4E-1 |
| GOTERM_BP_DIRECT | flavonoid glucuronidation | 3 | 6.3E-2 | 4.4E-1 |
| INTERPRO | UDP-glucuronosyl/UDP-glucosyltransferase | 3 | 6.6E-2 | 6.3E-1 |
| GOTERM_MF_DIRECT | transferase activity, transferring hexosyl groups | 3 | 9.1E-2 | 6.9E-1 |
| UP_KEYWORDS | Transferase | 7 | 4.7E-1 | 9.9E-1 |
| GOTERM_MF_DIRECT | transferase activity | 6 | 5.9E-1 | 1.0E0 |
| Category | Term | Count | PValue | Benjamini |
| GOTERM_BP_DIRECT | oxidation-reduction process | 6 | 1.8E-1 | 8.0E-1 |
| UP_KEYWORDS | Oxidoreductase | 4 | 2.6E-1 | 9.5E-1 |
| GOTERM_MF_DIRECT | oxidoreductase activity | 5 | 2.6E-1 | 9.6E-1 |
| Category | Term | Count | PValue | Benjamini |
| UP_SEQ_FEATURE | signal peptide | 4 | 9.6E-2 | 9.1E-1 |
| UP_SEQ_FEATURE | glycosylation site:N-linked (GlcNAc. . .) | 3 | 3.3E-1 | 9.6E-1 |
| UP_KEYWORDS | Glycoprotein | 3 | 8.2E-1 | 1.0E0 |
| Category | Term | Count | PValue | Benjamini |
| KEGG_PATHWAY | Metabolic pathways | 5 | 3.3E-1 | 9.8E-1 |
| UP_KEYWORDS | Zinc | 5 | 6.4E-1 | 1.0E0 |
| GOTERM_MF_DIRECT | zinc ion binding | 5 | 7.3E-1 | 1.0E0 |
| UP_KEYWORDS | Metal-binding | 6 | 8.5E-1 | 1.0E0 |
| GOTERM_MF_DIRECT | metal ion binding | 7 | 9.1E-1 | 1.0E0 |
| Category | Term | Count | PValue | Benjamini |
| GOTERM_CC_DIRECT | integral component of membrane | 21 | 7.6E-1 | 9.9E-1 |
| GOTERM_CC_DIRECT | membrane | 20 | 8.7E-1 | 1.0E0 |
| UP_KEYWORDS | Transmembrane helix | 21 | 1.0E0 | 1.0E0 |
| UP_KEYWORDS | Transmembrane | 21 | 1.0E0 | 1.0E0 |
| UP_KEYWORDS | Membrane | 21 | 1.0E0 | 1.0E0 |
Predicted protein sequences of T22D1.2, clx-1 and C50F7.5.
P: Proline, NAS: Potential N-glycosylation site. Repetitive sequences are displayed in italics and the complete site of repetition is underlined.
Fig 2Quantitative RT-PCR.
Relative normalized expression of ugt-44, pud-1.1, F13E9.4 and T22D1.2 mRNA following the treatment with OPC enriched fraction “H3” or C. mucronatum extract (ethanol: water 1:1; “RE”); 0.02, 0.2 and 2: concentrations of 0.02 mg/mL, 0.2 mg/mL and 2 mg/mL respectively. Data are presented on a log2 scale, the line at 1.0 indicates the expression level of the negative control (DMSO 1%).
Fig 3Representative images of C. elegans expressing pT22D1.2::GFP depending on treatment with hydroethanolic extract from C. mucronatum.
A: negative control (DMSO 1%); B: treatment with 0.2 mg/mL extract; C: treatment with 2 mg/mL extract. Scale bars = 100 μm.
Fig 4Representative images of C. elegans expressing numr-1::GFP depending on treatment with the hydroethanolic extract from C. mucronatum.
A: negative control (DMSO 1%); B: treatment with 0.2 mg/mL extract; C: treatment with 2 mg/mL extract. Scale bars = 100 μm.